Document is current
Any future updates will be listed below
-
Authors
Maev, Igor V
Samsonov, Aleksey A
Palgova, Liudmila K
Pavlov, Chavdar S
Shirokova, Elena N
Vovk, Elena I
Starostin, Kirill M https://orcid.org/0000-0001-6488-7980
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00063622 at ClinicalTrials.govDocuments that mention this clinical trial
Association between metabolic syndrome and liver histology among NAFLD patients without diabetes
https://doi.org/10.1136/bmjgast-2016-000114
Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia
https://doi.org/10.1136/bmjgast-2019-000368
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
https://doi.org/10.1136/gutjnl-2019-319104
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
https://doi.org/10.1136/gutjnl-2022-327498
Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
https://doi.org/10.1016/j.cct.2016.02.012
Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
https://doi.org/10.1016/j.cct.2008.09.003
-
Funding
Funding for this research was provided by:
Sanofi, France
- License Information
